Topic: Topic: Head and Neck Cancer Translational Medicine
Memorial Sloan Kettering physician-scientist Charles Sawyers, MD, specializes in new drug development for leukemias, prostate cancer, and glioblastoma. He has identified cell signaling components critical to the growth of cancer cells in chronic myeloid leukemia, prostate and other cancers, resulting in the development of multiple FDA-approved inhibitors in clinical use today.
Breakthroughs in Cancer seminar series is one of the highest-profile seminar series for translational and clinical scientists in oncology. The series brings national leaders in cancer research to Stanford’s campus and highlights innovations across the spectrum of basic, translational, clinical, and population science.
#oncology #cancerresearch #sciencemedicine
Learn more about our Breakthroughs in Cancer seminar series: med.stanford.edu/cancer/train...
Learn more about the Stanford Cancer Institute:
med.stanford.edu/cancer
Follow the Stanford Cancer Institute LinkedIn: / stanford-cancer
Twitter: / scidirector
Instagram: / stanford.cancer
Subscribe to the Stanford Cancer Institute: / @stanfordcancerinstitute